TMEM8B Antikörper (Middle Region)
Quick Overview for TMEM8B Antikörper (Middle Region) (ABIN630419)
Target
Alle TMEM8B Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Middle Region
-
Spezifität
- C9 ORF127 antibody was raised against the middle region of C9 rf127
-
Aufreinigung
- Purified
-
Immunogen
- C9 ORF127 antibody was raised using the middle region of C9 rf127 corresponding to a region with amino acids THNYLYAACECKAGWRGWGCTDSADALTYGFQLLSTLLLCLSNLMFLPPV
-
-
-
-
Applikationshinweise
-
WB: 5 µg/mL, IHC: 4-8 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
C9ORF127 Blocking Peptide, catalog no. 33R-9108, is also available for use as a blocking control in assays to test for specificity of this C9ORF127 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of C0 RF127 antibody in PBS
-
Konzentration
- Lot specific
-
Buffer
- PBS
-
Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- TMEM8B (Transmembrane Protein 8B (TMEM8B))
-
Andere Bezeichnung
- C9ORF127
-
Hintergrund
- The down-regulation of C9orf127 may be closely associated with tumorigenesis and metastasis of colorectal carcinoma. However, it may not contribute to the development and progression of gastric carcinoma.
-
Molekulargewicht
- 52 kDa (MW of target protein)
Target
-